Irene G. Van Hellemond

Eindhoven, NB, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Evolution of Prognosis and Management in Curative Treatment of Locally Recurrent Rectal Cancer: A Comprehensive Analysis from 2000 to 2023.

Evolution of Prognosis and Management in Curative Treatment of Locally Recurrent Rectal Cancer: A Comprehensive Analysis from 2000 to 2023.

Journal: Annals of surgical oncology

Published: May 12, 2026

Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial.

Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: December 16, 2025

Impact of pre-segmented regions on CT-based evaluation of the Peritoneal Cancer Index: A reader study.

Impact of pre-segmented regions on CT-based evaluation of the Peritoneal Cancer Index: A reader study.

Journal: PloS one

Published: December 10, 2025

Association Between Socioeconomic Position and Diagnosis, Treatment and Survival of Patients With Stage I-III Rectal Cancer in the Netherlands.

Association Between Socioeconomic Position and Diagnosis, Treatment and Survival of Patients With Stage I-III Rectal Cancer in the Netherlands.

Journal: International journal of cancer

Published: December 02, 2025

Income, treatment patterns and outcome in patients with stage IV colorectal cancer.

Income, treatment patterns and outcome in patients with stage IV colorectal cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 01, 2025

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis.

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis.

Journal: The Lancet. Oncology

Published: November 20, 2025

Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study.

Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study.

Journal: The Lancet regional health. Europe

Published: November 14, 2025

Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study.

Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 05, 2025

Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in Patients With High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT Trial.

Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in Patients With High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT Trial.

Journal: International journal of radiation oncology, biology, physics

Published: October 01, 2025

Effects of exercise and diet in patients with incurable gastroesophageal cancer: the RADICES study.

Effects of exercise and diet in patients with incurable gastroesophageal cancer: the RADICES study.

Journal: JNCI cancer spectrum

Published: August 29, 2025

Health-Related Quality of Life in Adolescents and Young Adults With an Uncertain or Poor Cancer Prognosis: Quantitative Baseline Results of the CORD-AYA Study.

Health-Related Quality of Life in Adolescents and Young Adults With an Uncertain or Poor Cancer Prognosis: Quantitative Baseline Results of the CORD-AYA Study.

Journal: Psycho-oncology

Published: July 31, 2025

Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastases.

Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastases.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 23, 2025

Showing 1-12 of 43

Last Updated: 09/26/2026